Filter announcements
Loading...
Incorporated in 2010, JFL Life Sciences Limited manufactures pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets & Capsules (B-Lactam) solid oral dosage forms tablets and capsules (general) Solid Oral Dosage forms, and Oral rehydration solutions (ORS).
JFL Life Sciences has announced a board meeting on May 19, 2025, which approved the audited financial results for the quarter and half-year ended March 31, 2025. The audit report was issued with an unmodified opinion, indicating a clean bill of health. For the 6 months ended March 31, 2025,...